• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在法国,患有多发性硬化症的北非人比欧洲人残疾情况更严重。

More severe disability of North Africans vs Europeans with multiple sclerosis in France.

作者信息

Debouverie M, Lebrun C, Jeannin S, Pittion-Vouyovitch S, Roederer T, Vespignani H

机构信息

Department of Neurology, Central Hospital, Nancy, France.

出版信息

Neurology. 2007 Jan 2;68(1):29-32. doi: 10.1212/01.wnl.0000250347.51674.d7.

DOI:10.1212/01.wnl.0000250347.51674.d7
PMID:17200488
Abstract

OBJECTIVE

To compare the clinical disease progression in European (E) and North African (NA) patients with multiple sclerosis (MS) patients in France.

METHODS

We compared the clinical features of MS in 211 NA patients and 2,945 E patients in a French population-based cohort with definite MS according to McDonald's criteria.

RESULTS

Among the NA patients with MS, 66.4% were women vs 72.9% of the E patients (p = 0.04), 15.6% had a primary progressive form of MS vs 11.7% of the E patients (p = 0.08), and the mean age at onset was 29.9 +/- 9.8 years in the NA patients vs 32.9 +/- 10.6 years in the E patients (p < 0.0001). In the NA patients, there was a higher proportion of patients with incomplete recovery from the first relapse (p < 0.0001), a shorter time between the first two relapses (p = 0.02), a higher number of relapses in the first 5 years (p = 0.03), and a shorter time to reach an Expanded Disability Status Scale score of 4.0 (p = 0.001) or 6.0 (p < 0.0001). The only statistical difference in these factors between NA patients born in France and those born in North Africa was the mean age at onset of symptoms: it was earlier in NA patients born in France (p < 0.0001).

CONCLUSIONS

The course of multiple sclerosis is more aggressive in North African than in European patients.

摘要

目的

比较法国欧洲裔(E)和北非裔(NA)多发性硬化(MS)患者的临床疾病进展情况。

方法

我们在一个基于法国人群的队列中,根据麦克唐纳标准对211例NA患者和2945例E患者的MS临床特征进行了比较。

结果

在患有MS的NA患者中,66.4%为女性,而E患者中这一比例为72.9%(p = 0.04);15.6%患有原发性进行性MS,而E患者中这一比例为11.7%(p = 0.08);NA患者的平均发病年龄为29.9±9.8岁,E患者为32.9±10.6岁(p < 0.0001)。在NA患者中,首次复发后未完全恢复的患者比例更高(p < 0.0001),前两次复发之间的时间更短(p = 0.02),前5年的复发次数更多(p = 0.03),达到扩展残疾状态量表评分4.0(p = 0.001)或6.0(p < 0.0001)的时间更短。在法国出生的NA患者和在北非出生的NA患者之间,这些因素的唯一统计学差异是症状的平均发病年龄:在法国出生的NA患者中发病年龄更早(p < 0.0001)。

结论

多发性硬化的病程在北非患者中比在欧洲患者中更具侵袭性。

相似文献

1
More severe disability of North Africans vs Europeans with multiple sclerosis in France.在法国,患有多发性硬化症的北非人比欧洲人残疾情况更严重。
Neurology. 2007 Jan 2;68(1):29-32. doi: 10.1212/01.wnl.0000250347.51674.d7.
2
[The organisation of health care and epidemiology of multiple sclerosis in France].[法国的医疗保健组织与多发性硬化症流行病学]
Rev Neurol (Paris). 2007 Jun;163(6-7):637-45. doi: 10.1016/s0035-3787(07)90472-5.
3
Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study.法国北非移民多发性硬化症表型的代际变化:一项基于人群的观察性研究。
PLoS One. 2018 Mar 27;13(3):e0194115. doi: 10.1371/journal.pone.0194115. eCollection 2018.
4
Impact of disease-modifying treatments in North African migrants with multiple sclerosis in France.疾病修饰治疗对法国北非裔多发性硬化症移民的影响。
Mult Scler. 2008 Aug;14(7):933-9. doi: 10.1177/1352458508091369. Epub 2008 Jun 23.
5
Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?突尼斯多发性硬化症的临床特征与残疾进展:我们真的患有更具侵袭性的病程吗?
J Neurol Sci. 2014 Aug 15;343(1-2):110-4. doi: 10.1016/j.jns.2014.05.049. Epub 2014 Jun 2.
6
Fast multiple sclerosis progression in North Africans: Both genetics and environment matter.北非人群中多发性硬化症的快速进展:遗传因素和环境因素都至关重要。
Neurology. 2017 Mar 28;88(13):1218-1225. doi: 10.1212/WNL.0000000000003762. Epub 2017 Feb 24.
7
[Phenotypical aspects and clinical course of multiple sclerosis in 76 patients with a North African ethnic background followed at the Nice University Hospital].[在尼斯大学医院随访的76名具有北非种族背景的多发性硬化症患者的表型特征和临床病程]
Rev Neurol (Paris). 2007 Apr;163(4):440-7. doi: 10.1016/s0035-3787(07)90419-1.
8
Granulomatosis with polyangiitis according to geographic origin and ethnicity: clinical-biological presentation and outcome in a French population.根据地理来源和种族划分的肉芽肿性多血管炎:法国人群中的临床生物学表现及预后
Rheumatology (Oxford). 2017 Mar 1;56(3):445-450. doi: 10.1093/rheumatology/kew423.
9
Multiple sclerosis in North African migrants to France.移居法国的北非移民中的多发性硬化症
Acta Neurol Scand. 1998 Nov;98(5):302-9. doi: 10.1111/j.1600-0404.1998.tb01738.x.
10
Migration and age at onset of multiple sclerosis: some pitfalls of migrant studies.多发性硬化症的迁移与发病年龄:移民研究中的一些陷阱
Acta Neurol Scand. 1992 Jun;85(6):408-11. doi: 10.1111/j.1600-0404.1992.tb06038.x.

引用本文的文献

1
Multiple Sclerosis in People of Diverse Racial and Ethnic Backgrounds: Presentation, Disease Course, and Interactions with Disease-Modifying Therapy.不同种族和族裔背景人群中的多发性硬化症:临床表现、疾病进程以及与疾病修正治疗的相互作用
CNS Drugs. 2025 Jul 18. doi: 10.1007/s40263-025-01205-4.
2
Prognostic factors of disability progression in multiple sclerosis in real life: the OFSEP-high definition (OFSEP-HD) prospective cohort in France.现实生活中多发性硬化症残疾进展的预后因素:法国的OFSEP-高清(OFSEP-HD)前瞻性队列研究
BMJ Open. 2025 Apr 7;15(4):e094688. doi: 10.1136/bmjopen-2024-094688.
3
Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center study.
以色列阿什肯纳兹犹太人与非阿什肯纳兹犹太患者多发性硬化症临床和流行病学特征的差异:一项回顾性单中心研究。
Sci Rep. 2022 Mar 16;12(1):4555. doi: 10.1038/s41598-022-08565-7.
4
Determinants of disability development in patients with multiple sclerosis.多发性硬化症患者残疾发展的决定因素。
Arq Neuropsiquiatr. 2021 Jun;79(6):489-496. doi: 10.1590/0004-282X-ANP-2020-0338.
5
Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region.中东和北非(MENA)地区多发性硬化症的流行病学与表型
Mult Scler J Exp Transl Clin. 2020 Jan 14;6(1):2055217319841881. doi: 10.1177/2055217319841881. eCollection 2020 Jan-Mar.
6
Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study.法国北非移民多发性硬化症表型的代际变化:一项基于人群的观察性研究。
PLoS One. 2018 Mar 27;13(3):e0194115. doi: 10.1371/journal.pone.0194115. eCollection 2018.
7
MS in self-identified Hispanic/Latino individuals living in the US.在美国自我认定为西班牙裔/拉丁裔的人群中的硕士学位情况。
Mult Scler J Exp Transl Clin. 2017 Sep 25;3(3):2055217317725103. doi: 10.1177/2055217317725103. eCollection 2017 Jul-Sep.
8
Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.分泌白细胞介素-17和白细胞介素-22的、对皮质激素耐药的髓鞘特异性CD4(+) T细胞与多发性硬化症患者的活动性脑损伤有关。
Immunology. 2016 Feb;147(2):212-20. doi: 10.1111/imm.12552. Epub 2015 Dec 2.
9
Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis.患有多发性硬化症的黑人患者脑脊液中的寡克隆带
Biomed Res Int. 2015;2015:217961. doi: 10.1155/2015/217961. Epub 2015 Jul 29.
10
No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.在一个基于人群的407例多发性硬化症患者队列中,常规脑脊液生物标志物无预后价值。
BMC Neurol. 2015 May 13;15:79. doi: 10.1186/s12883-015-0330-4.